Lv1
50 积分 2024-11-22 加入
Cost-Effectiveness Analysis of Evolocumab or Inclisiran in Combination with Statins Versus Statin Monotherapy Among Patients with ASCVD in China
6小时前
待确认
Efficacy, Safety, and Cost-effectiveness Analysis of Antiviral Agents for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation Recipients
16天前
已完结
Cost-effectiveness of adding ezetimibe and/or PCSK9 inhibitors to high-dose statins for secondary prevention of cardiovascular disease in Chinese adults
1个月前
已完结
PREVENTION OF SLOW FLOW/NO REFLOW DURING PERCUTANEOUS CORONARY INTERVENTION BY A SINGLE DOSE OF PCSK9 INHIBITOR THERAPY
2个月前
已关闭
PREVENTION OF SLOW FLOW/NO REFLOW DURING PERCUTANEOUS CORONARY INTERVENTION BY A SINGLE DOSE OF PCSK9 INHIBITOR THERAPY
2个月前
已关闭
Adjunctive PCSK9 Inhibitor Evolocumab in the Prevention of Early Neurological Deterioration in Non-cardiogenic Acute Ischemic Stroke: A Multicenter, Prospective, Randomized, Open-Label, Clinical Trial
2个月前
已完结
Early Use of PCSK9 Inhibitors in the Prognosis of Patients with Acute Coronary Syndrome by Protecting Vascular Endothelial Function
2个月前
已完结
Long-Term Cognitive Safety of Achieving Very Low LDL Cholesterol with Evolocumab
2个月前
已完结
Effect of PCSK9 inhibitors on major cardiac adverse events and lipoprotein-a in patients with coronary heart disease: a meta-analysis
3个月前
已完结
Recaticimab as Add-On Therapy to Statins for Nonfamilial Hypercholesterolemia
3个月前
已完结
皖公网安备34019202002308
